Alzheimer Disease News
- Alert FDA Approves Second Anti-Amyloid for Alzheimer's Disease
- Lecanemab Linked to Death in AD Patient With Stroke Given tPA
- Congressional Report: FDA Broke Own Protocols in Approving Biogen Alzheimer's Drug
- Strong Link Between Muscle Strength, Mobility, and Brain Health
- Green, Blue Space Linked to Fewer Parkinson's Hospitalizations
- Eisai, Biogen's New Alzheimer's Drug Should Be Priced Below Aduhelm: Report
- Alzheimer's Association to CMS: Ditch Restraints on Amyloid Drugs
- Psychological Distress May Up Dementia Risk
- Is There Hope in the Fight Against Aging?
- Genetic Predisposition to ADHD Linked to Alzheimer's Risk
- AES 2022 Seizures in Dementia Hasten Decline and Death
- Alert FDA Clears Two Biomarker Assays for Early Alzheimer's Detection
- CTAD 2022 Exercise to Prevent Cognitive Decline in MCI: New Data
- Voice Could Be a Major New Biomarker
- Off-Label Use of Dementia Meds Tied to Lower Mortality in DLB
- Ultraprocessed Foods Tied to Faster Rate of Cognitive Decline
- Lecanemab a Game-Changer for Alzheimer's? Not So Fast
- CTAD 2022 Antipsychotic Shows Benefit for Alzheimer's Agitation
- 'Convincing Evidence' Hearing Aids Reduce Dementia Risk
- CTAD 2022 Personalized Approach to Alzheimer's Risk Factors Boosts Cognition